HER2 overexpression has been described in hepatoma cells (H4IIE, HepG2, JM1, McA-RH7777) and HCC cells collected from patients, compared to normal mature hepatocytes and cells from adjacent tumor parenchyma. Here, ERBB2 is linked to hepatocellular carcinoma.